ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1931

Health System Improvement in Appropriate Test Utilization Involving ANA Testing in the Inpatient and Outpatient Setting

Benjamin Wolff1, Nayeon Oh2, Amy Slenker3, Kathryn Zaffiri3, Rahul Mhaskar4 and Marie O'Brien5, 1Lehigh Valley Health Network - Internal Medicine Residency, Macungie, PA, 2Univeristy of South Florida, Allentown, PA, 3Lehigh Valley Health Network, Allentown, PA, 4University of South Florida, Tampa, FL, 5Lehigh Valley Hospital and Health Network, Orefield, PA

Meeting: ACR Convergence 2024

Keywords: Health Care, lupus-like disease, quality of care

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Health Services Research – ACR/ARP Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: To manage patients In the current healthcare environment, objective data and laboratory tests drive medical decision making. This has led to an increase in inappropriate test utilization. Previously, Lehigh Valley Health Network (LVHN) instituted an order set for Antinuclear Antibody (ANA) serologic testing to facilitate more efficient work-up of a positive ANA. In the short term, this showed a significant decrease in inappropriate testing. Orders include ANA alone, ANA with Reflex where an ANA > 1:80 is reflexed to additional serologic testing, and Comprehensive ANA which includes the same serologic testing but no positive ANA requirement. Benefits of the ANA with Reflex panel include a rapid cost-effective diagnostic assessment.  The cost of the Comprehensive ANA is $287.19 and an ANA reflex is $34.34. The goal of this quality improvement project was to determine ANA order frequency and appraisal of educational and electronic medical record (EMR) interventions for appropriate testing in the inpatient and outpatient settings.

Methods: ANA testing orders were reviewed from November 2020 to January 2024. Two different interventions were implemented in the inpatient segment of this project. The primary intervention was implemented 15 months into the project and included education of clinicians via EMR alert and removal of the comprehensive ANA order from order lists (Figure 1). In the outpatient setting, provider education was implemented via the same alert as above along with subsequent removal of the comprehensive ANA from clinician lists on February 28th, 2024. Inpatient data was further analyzed by specific departments. Chi-Square Analysis and comparison of proportions analysis were used to determine statistical significance.

Results: In the outpatient setting, the intervention reduced the total number of ANA tests from 15.9% of tests ordered to 7.4%, comprehensive ANA from 22.8% to 13.4%, and increased ANA reflex orders from 61.3% to 79.3% (Table 1). In the inpatient setting,  the intervention reduced the number of ANA tests from 25.5% to 6.4%, comprehensive ANA from 33.3% to 2.1%, and increased ANA reflex orders from 41.3% to 91.5% (Table 2).  $443,628 were spent on ANA testing prior to intervention which decreased to $134,102 in the 22 months after intervention. Comparison of proportions analysis between inpatient and outpatient testing demonstrated the inpatient intervention was statistically more successful. (P< 0.001).

Conclusion: Focused educational initiatives and EMR enhancements in the inpatient and outpatient setting at LVHN have significantly improved operational efficiency and cost-effectiveness of ANA testing protocols. The decrease in Comprehensive ANA testing led to significant savings for both patients and the healthcare system. This ANA testing intervention is not only applicable to our healthcare system, but could also be replicated by healthcare systems nationwide. Outpatient intervention has only recently occurred, but there is a noticeable shift in the amount of comprehensive ANA tests being ordered and this will continue to be analyzed moving forward. 

Supporting image 1

Table 1. Outpatient ANA Studies

Supporting image 2

Table 2. Inpatient ANA Studies

Supporting image 3

Figure 1. Diagnostic Testing in Patients with Suspected Rheumatic Disease


Disclosures: B. Wolff: None; N. Oh: None; A. Slenker: None; K. Zaffiri: None; R. Mhaskar: None; M. O'Brien: None.

To cite this abstract in AMA style:

Wolff B, Oh N, Slenker A, Zaffiri K, Mhaskar R, O'Brien M. Health System Improvement in Appropriate Test Utilization Involving ANA Testing in the Inpatient and Outpatient Setting [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/health-system-improvement-in-appropriate-test-utilization-involving-ana-testing-in-the-inpatient-and-outpatient-setting/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/health-system-improvement-in-appropriate-test-utilization-involving-ana-testing-in-the-inpatient-and-outpatient-setting/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology